Draxis Health Inc /CN/ - Report of Foreign Issuer (6-K)
27 Mai 2008 - 8:39PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE
COMMISSION
Washington,
DC 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER
Pursuant
to Rule 13a-16 or 15-d-16 of
The
Securities Exchange Act of 1934
For
May 27, 2008
Commission
File Number 000-17434
DRAXIS HEALTH INC.
(Translation
of registrants name into English)
Suite
4700, TD Bank Tower
Toronto
Dominion Centre
Toronto,
Ontario M5K 1E6
CANADA
(Address of principal offices)
Registrant
files annual reports under cover of Form 20-F
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
DRAXIS
HEALTH INC.
|
|
|
|
|
By: /s/ Alida Gualtieri
|
General
Counsel & Secretary
|
Dated: May 27, 2008
2
Draxis Health (MM) (NASDAQ:DRAX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Draxis Health (MM) (NASDAQ:DRAX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
Echtzeit-Nachrichten über Draxis Health (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Draxis Health Inc /CN/ News-Artikel